US Stock MarketDetailed Quotes

NDRAW Endra Life Sciences Inc C/Wts 08/05/2022 (To Pur Com)

Watchlist
  • 0.000
  • 0.0000.00%
Close Dec 4 09:30 ET
0Market Cap0.00P/E (TTM)

About Endra Life Sciences Inc C/Wts 08/05/2022 (To Pur Com) Company

ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI, but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.

Company Profile

SymbolNDRAW
Company NameEndra Life Sciences Inc C/Wts 08/05/2022 (To Pur Com)
CEOMr. Francois Michelon
MarketNASDAQ
Employees18

Company Executives

  • Name
  • Position
  • Salary
  • Francois Michelon
  • Chairman of the Board and Chief Executive Officer
  • --
  • Renaud Maloberti
  • Chief Commercial Officer
  • --
  • Michael Thornton
  • Chief Technology Officer
  • --
  • Irina Pestrikova
  • Senior Director, Finance, Principal Financial Officer and Principal Accounting Officer
  • --
  • Alexander Y. Tokman
  • Independent Director
  • --
  • Louis J. Basenese
  • Independent Director
  • --
  • Anthony Digiandomenico
  • Independent Director
  • --
  • Michael Harsh
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data